Management Team
Ray Takigiku, PhD - President and CEO
Previously was Director of Discovery Core Technologies, Analytical and
Bioanalytical for Procter & Gamble Pharmaceuticals, and also Interim co-Director
of the Genome Research Institute of the College of Medicine, University of
Cincinnati. At P&G, he led development and implementation of new technologies
to discover, and develop novel drugs. He also managed the global analytical and
bioanalytical functions in support of preclinical, clinical drug development, and
market support activities. He has more than 18-year industry experience in drug
discovery and development within a large pharmaceutical company setting. Dr.
Takigiku participated in the filing of several INDs and multiple NDAs, ANDAs, and
sNDAs. Dr. Takigiku received his BA from University of Colorado, and Ph.D. from
Indiana University.
Previously was Director of Discovery Core Technologies, Analytical and
Bioanalytical for Procter & Gamble Pharmaceuticals, and also Interim co-Director
of the Genome Research Institute of the College of Medicine, University of
Cincinnati. At P&G, he led development and implementation of new technologies
to discover, and develop novel drugs. He also managed the global analytical and
bioanalytical functions in support of preclinical, clinical drug development, and
market support activities. He has more than 18-year industry experience in drug
discovery and development within a large pharmaceutical company setting. Dr.
Takigiku participated in the filing of several INDs and multiple NDAs, ANDAs, and
sNDAs. Dr. Takigiku received his BA from University of Colorado, and Ph.D. from
Indiana University.
Ellen Monson, PhD - Senior VP
Previously was Director of Intellectual Property Office, University of Cincinnati.
Worked in biological drug development at Eli Lilly. Dr. Monson received her PhD
(1994) at University of California San Diego and Post-Doc experience at Fred
Hutchinson Cancer Research Center and Princeton University.
Previously was Director of Intellectual Property Office, University of Cincinnati.
Worked in biological drug development at Eli Lilly. Dr. Monson received her PhD
(1994) at University of California San Diego and Post-Doc experience at Fred
Hutchinson Cancer Research Center and Princeton University.
Kevin Xu, MD, PhD, MBA - VP of Global Operations
Previously was Senior Research Scientist at Procter & Gamble Pharmaceuticals.
He has 11-year experience in clinical medicine, biomedical research and drug
R&D. Dr. Xu received his medical training from the Medical College of Peking
University, China, and his Ph.D. in Biomedical Science (Tumor Biology) from the
Mayo Graduate School of the Mayo Clinic, Minnesota. He has an M.B.A. from
Xavier University, Ohio.
Previously was Senior Research Scientist at Procter & Gamble Pharmaceuticals.
He has 11-year experience in clinical medicine, biomedical research and drug
R&D. Dr. Xu received his medical training from the Medical College of Peking
University, China, and his Ph.D. in Biomedical Science (Tumor Biology) from the
Mayo Graduate School of the Mayo Clinic, Minnesota. He has an M.B.A. from
Xavier University, Ohio.
